14 Ways to Celebrate Asthma and Allergy Awareness Month
May is Allergy & Asthma Month, and dedicated to raising public awareness about asthma and allergies, their impact on people and their families.
-
-
Allergy & Asthma Network and Blue Marble Health Advance Digital Health Innovation with Evidence-Based Platform for Asthma Self-Management
Pilot testing of a Allergy & Asthma Network and Blue Marble Health digital platform demonstrates high usability and strong potential to expand equitable access to asthma self-management education.
-
New Generic for Flovent® Asthma Inhaler: What You Need to Know
If you use Flovent HFA and Flovent Diskus, reach out to your healthcare provider and find out about alternatives, including generics.
-
Stop Trusting AI with Your Health! Allergy & Asthma Network is the Real Expert
You hear a lot about new computer programs, like AI chatbots (ChatGPT, Claude, Gemini, etc.) that can give you fast answers. But when it comes to your health, a fast answer can be a very wrong answer. When you’re dealing with asthma and allergies, you want advice you can trust. The Danger of an AI…
-
Food Allergy Symptoms: Mild vs. Serious
When people think of food allergy symptoms, they often picture sudden, dramatic and severe reactions. But not all food allergy symptoms are severe. In fact, many people experience mild food reactions. How do you know if you or a loved one is experiencing a mild food reaction vs. a severe food reaction? A recent survey…
-
News | Allergies | Medication
With Palforzia® Ending, What’s Next for Peanut Allergy Patients?
The peanut allergy treatment Palforzia® will be discontinued on July 31, 2026, according to its manufacture.
-
Allergy & Asthma Network Opposes EPA Repeal of the Endangerment Finding
FAIRFAX, VA, FEB. 13, 2026 – Allergy & Asthma Network issued the following statement in response to the U.S. Environmental Protection Agency’s (EPA) final decision on Feb. 12 to repeal the 2009 Endangerment Finding: Allergy & Asthma Network strongly opposes the EPA’s decision to implement final repeal of the 2009 Endangerment Finding. “This action…
-
Chronic Urticaria: Antihistamines, Biologics, and BTK Inhibitors (New Webinar)
Join us for a FREE webinar | April 16, 2026| 4 PM ET Chronic urticaria is a complex and often persistent condition that presents ongoing management challenges for clinicians. Optimal care frequently requires a stepwise therapeutic approach, careful monitoring of treatment response, and familiarity with emerging therapies as the treatment landscape continues to evolve. In…
-
Does your toddler have a peanut allergy?
If your child has or may have a peanut allergy, we ask you to consider the COMFORT Toddlers study. It may help us learn more about treating peanut allergy in toddlers.
-
How to Report Food Label Issues for Food Allergies
If you or a loved one live with a food allergy, then you know the importance of reading food labels. Food labels identify the ingredients in your food. They also highlight if common allergens are present. What can you do if you have a severe allergic reaction to a food you thought was “safe” based…
-
Struggling to manage chronic urticaria symptoms (hives)?
Consider enrolling in the BLU-808-1201 clinical research study. You may qualify if you have chronic spontaneous urticaria and are still experiencing symptoms such as hives even after taking antihistamines. Participation lasts at least 4 months and includes the following:
-
Allergy & Asthma Network Applauds Congressional Funding for the National Asthma Control Program
Allergy & Asthma Network applauds Congress for approving funding for the CDC’s National Asthma Control Program.
End of content
End of content
